These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38747565)

  • 1. Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration.
    Leyens L; Batchelor J; De Beuckelaer E; Langel K; Hartog B
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jul; 24(6):731-741. PubMed ID: 38747565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers.
    Otte M; Dauben HP; Ahn J; Gutierrez Ibarluzea I; Drummond M; Simoens S; Kaló Z; Suh DC
    Expert Rev Pharmacoecon Outcomes Res; 2024 Nov; 24(9):1061-1066. PubMed ID: 39221874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation.
    Kruizinga MD; Stuurman FE; Exadaktylos V; Doll RJ; Stephenson DT; Groeneveld GJ; Driessen GJA; Cohen AF
    Pharmacol Rev; 2020 Oct; 72(4):899-909. PubMed ID: 32958524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for the Clinical Validation of Digital Endpoints: Protocol for a Scoping Review Abstract.
    Rego S; Henriques AR; Serra SS; Costa T; Rodrigues AM; Nunes F
    JMIR Res Protoc; 2023 Oct; 12():e47119. PubMed ID: 37883152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence.
    Ciani O; Grigore B; Taylor RS
    Health Econ; 2022 Sep; 31 Suppl 1(Suppl 1):44-72. PubMed ID: 35608044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Language Matters in Digital Endpoint Development: Harmonized Terminology as a Key Prerequisite for Evidence Generation.
    Leyens L; Northcott CA; Maloney L; McCarthy M; Dokuzova N; Pfister T; ;
    Digit Biomark; 2024; 8(1):1-12. PubMed ID: 38222479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging sensor-based functional outcomes to enhance understanding of the patient experience: challenges and opportunities.
    Keyloun KR; Abel J; Garcia JK; Papadopoulos EJ; Carson RT; Gwaltney C; Slagle AF; Byrom B
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jul; 24(6):723-730. PubMed ID: 38828646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing pharmacy and healthcare with virtual digital technologies.
    Trenfield SJ; Awad A; McCoubrey LE; Elbadawi M; Goyanes A; Gaisford S; Basit AW
    Adv Drug Deliv Rev; 2022 Mar; 182():114098. PubMed ID: 34998901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event.
    Tackney MS; Steele A; Newman J; Fritzsche MC; Lucivero F; Khadjesari Z; Lynch J; Abbott RA; Barber VS; Carpenter JR; Copsey B; Davies EH; Dixon WG; Fox L; González J; Griffiths J; Hinchliffe CHL; Kolanko MA; McGagh D; Rodriguez A; Roussos G; So KBE; Stanton L; Toshner M; Varian F; Williamson PR; Yimer BB; Villar SS
    Trials; 2024 Aug; 25(1):521. PubMed ID: 39095915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitizing nursing: A theoretical and holistic exploration to understand the adoption and use of digital technologies by nurses.
    Wynn M; Garwood-Cross L; Vasilica C; Griffiths M; Heaslip V; Phillips N
    J Adv Nurs; 2023 Oct; 79(10):3737-3747. PubMed ID: 37530425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.
    Love-Koh J; Peel A; Rejon-Parrilla JC; Ennis K; Lovett R; Manca A; Chalkidou A; Wood H; Taylor M
    Pharmacoeconomics; 2018 Dec; 36(12):1439-1451. PubMed ID: 30003435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world.
    Jones CH; Madhavan S; Natarajan K; Corbo M; True JM; Dolsten M
    Drug Discov Today; 2024 Sep; 29(9):104112. PubMed ID: 39053620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
    Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.
    Phillips KA; Douglas MP; Trosman JR; Marshall DA
    Value Health; 2017 Jan; 20(1):47-53. PubMed ID: 28212968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
    Brogan AP; DeMuro C; Barrett AM; D'Alessio D; Bal V; Hogue SL
    J Manag Care Spec Pharm; 2017 Feb; 23(2):125-134. PubMed ID: 28125369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.
    Pinton P
    Ann Med; 2023; 55(2):2300670. PubMed ID: 38163336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment. The pharmaceutical industry perspective.
    Schubert F
    Int J Technol Assess Health Care; 2002; 18(2):184-91. PubMed ID: 12053418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the net financial benefits of employing digital endpoints in clinical trials.
    DiMasi JA; Dirks A; Smith Z; Valentine S; Goldsack JC; Metcalfe T; Grewal U; Leyens L; Conradi U; Karlin D; Maloney L; Getz KA; Hartog B
    Clin Transl Sci; 2024 Aug; 17(8):e13902. PubMed ID: 39072949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital technology and clinical decision making in depression treatment: Current findings and future opportunities.
    Hallgren KA; Bauer AM; Atkins DC
    Depress Anxiety; 2017 Jun; 34(6):494-501. PubMed ID: 28453916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.